[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ruiz-Rodríguez et al., 2021 - Google Patents

Deep phenotypic characterisation of CTCs by combination of microfluidic isolation (IsoFlux) and imaging flow cytometry (ImageStream)

Ruiz-Rodríguez et al., 2021

View HTML
Document ID
6490709334421442505
Author
Ruiz-Rodríguez A
Molina-Vallejo M
Aznar-Peralta I
González Puga C
Cañas García I
González E
Lorente J
Serrano M
Garrido-Navas M
Publication year
Publication venue
Cancers

External Links

Snippet

Simple Summary Cells that escape the primary tumour and have the potential ability to colonise distant organs through metastasis are called circulating tumour cells (CTCs). The study of CTCs in colorectal cancer (CRC) has demonstrated their prognostic utility, although …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/01—Social networking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation, e.g. computer aided management of electronic mail or groupware; Time management, e.g. calendars, reminders, meetings or time accounting

Similar Documents

Publication Publication Date Title
Manjunath et al. PD-L1 expression with epithelial mesenchymal transition of circulating tumor cells is associated with poor survival in curatively resected non-small cell lung cancer
Tang et al. B cells and tertiary lymphoid structures influence survival in lung cancer patients with resectable tumors
Rivera-Báez et al. Expansion of circulating tumor cells from patients with locally advanced pancreatic cancer enable patient derived xenografts and functional studies for personalized medicine
Ruiz-Rodríguez et al. Deep phenotypic characterisation of CTCs by combination of microfluidic isolation (IsoFlux) and imaging flow cytometry (ImageStream)
Ganau et al. How nanotechnology and biomedical engineering are supporting the identification of predictive biomarkers in neuro-oncology
Markopoulos et al. Touch imprint intraoperative flow cytometry as a complementary tool for detailed assessment of resection margins and tumor biology in liver surgery for primary and metastatic liver neoplasms
Klezl et al. Detection of circulating tumor cells in renal cell carcinoma: disease stage correlation and molecular characterization
Muchlińska et al. Detection and characterization of circulating tumor cells using imaging flow cytometry—a perspective study
Liao et al. The integration of a three-dimensional spheroid cell culture operation in a circulating tumor cell (CTC) isolation and purification process: a preliminary study of the clinical significance and prognostic role of the CTCs isolated from the blood samples of head and neck cancer patients
Bhakdi et al. Accuracy of tumour-associated circulating endothelial cells as a screening biomarker for clinically significant prostate cancer
Tashireva et al. Heterogeneous manifestations of epithelial–mesenchymal plasticity of circulating tumor cells in breast cancer patients
Padillo-Ruiz et al. Circulating tumor cells enumeration from the portal vein for risk stratification in early pancreatic cancer patients
Chudasama et al. Liquid biopsies in lung cancer: Four emerging technologies and potential clinical applications
Kulasinghe et al. The use of three-dimensional dna fluorescent in situ hybridization (3D DNA FISH) for the detection of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) circulating tumor cells
Jhi et al. Circulating tumor cells and TWIST expression in patients with metastatic gastric cancer: a preliminary study
Turetta et al. Assessment of the mutational status of nsclc using hypermetabolic circulating tumor cells
Neuperger et al. Analysis of the single-cell heterogeneity of adenocarcinoma cell lines and the investigation of intratumor heterogeneity reveals the expression of transmembrane protein 45A (TMEM45A) in lung adenocarcinoma cancer patients
Katsarou et al. Detyrosinated α-tubulin, vimentin and PD-L1 in circulating tumor cells (CTCs) isolated from non-small cell lung cancer (NSCLC) patients
Mazard et al. Clinical relevance of viable circulating tumor cells in patients with metastatic colorectal cancer: the COLOSPOT prospective study
Tang et al. Clinical applications of cancer-associated cells present in the blood of cancer patients
Kozuka et al. Clinical significance of circulating tumor cell induced epithelial-mesenchymal transition in patients with metastatic colorectal cancer by single-cell RNA-sequencing
Sulaiman et al. Identification and morphological characterization of features of circulating cancer-associated macrophage-like cells (CAMLs) in endometrial cancers
Jouida et al. Exosomes from EGFR-mutated adenocarcinoma induce a hybrid EMT and MMP9-dependant tumor invasion
Nanou et al. Endothelium-derived extracellular vesicles associate with poor prognosis in metastatic colorectal cancer
Pokrývková et al. PD1+ CD8+ cells are an independent prognostic marker in patients with Head and Neck Cancer